Biofrontera Inc. Income (Loss) from Equity Method Investments
Biofrontera Inc. (BFRI) reported Income (Loss) from Equity Method Investments of -$1.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-13
- Biofrontera Inc. income (loss) from equity method investments for the quarter ending 2025-12-31 was -$1.00K.
- Biofrontera Inc. income (loss) from equity method investments for the quarter ending 2025-09-30 was $1.00K.
- Biofrontera Inc. income (loss) from equity method investments for the quarter ending 2024-12-31 was -$2.00K.
- Biofrontera Inc. income (loss) from equity method investments for the quarter ending 2024-09-30 was -$1.00K.
- Biofrontera Inc. income (loss) from equity method investments for fiscal 2025 was $2.00K.
- Biofrontera Inc. income (loss) from equity method investments for fiscal 2024 was -$14.00K.
- Biofrontera Inc. income (loss) from equity method investments for fiscal 2023 was -$7.42M, a 524.79% decline from fiscal 2022.
- Biofrontera Inc. income (loss) from equity method investments for fiscal 2022 was $1.75M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $0.00 derived: sum of 2 quarters · filed 2026-03-19 | $2.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$3.00K derived: sum of 2 quarters · filed 2026-03-19 | -$17.00K derived: sum of 3 quarters · filed 2026-03-19 | -$14.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$15.00K derived: sum of 2 quarters · filed 2025-11-12 | -$12.00K 10-Q · filed 2025-11-12 | -$798.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$14.00K 10-Q · filed 2024-08-14 | -$11.00K 10-Q · filed 2025-08-13 | -$797.00K derived: sum of 3 quarters · filed 2025-05-15 | -$3.01M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $3.00K 10-Q · filed 2025-05-15 | -$783.00K derived: sum of 2 quarters · filed 2025-05-15 | -$3.00M derived: sum of 3 quarters · filed 2025-05-15 | -$4.48M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$786.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$3.00M derived: sum of 2 quarters · filed 2025-03-20 | -$4.48M derived: sum of 3 quarters · filed 2025-03-20 | -$7.42M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$2.21M 10-Q · filed 2023-11-09 | -$3.69M derived: sum of 2 quarters · filed 2024-08-14 | -$6.63M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$1.48M 10-Q · filed 2024-08-14 | -$4.42M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$2.94M 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $1.75M 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |